Search Results

Taking on big pharma's patent abuse is the right next step for Congress to lower health care costs.

• Authors : COCKFIELD, ALFRED S.

Subjects: PHARMACEUTICAL industry; MEDICAL care costs; DRUG patentsUNITED StatesUNITED StatesUNITED StatesReport Available

• Source: New York Amsterdam News. 9/14/2023, Vol. 114 Issue 37, p12-43. 2p.

Record details

Drug Industry Fights to Block Talks on Prices.

• Authors : STOLBERG, SHERYL GAY; ROBBINS, REBECCA

Subjects: *PRICES; *PHARMACEUTICAL industry; *INSURANCE premiums

• Source: New York Times. 7/23/2023, Vol. 172 Issue 59858, p1-14. 2p.

Record details

Haleon stock hit by drop in volumes.

• Source: The Times (London, England). 2024, pages. 31

Record details

Amazon shares eye record high in U.S. tech boom.

• Source: Daily Mail (London, England). 2024, pages. 56

Record details

Under Hipgnosis Shares slump as [...].

• Source: The London Evening Standard (London, England). 2024, pages. 19

Record details

Nvidia fever is here. Why the chipmaker is the worldâs hottest stock

• Authors : De Vynck, Gerrit; Abril, Danielle; Telford, Taylor

• Source: The Washington Post. March 15, 2024

Record details

Shares rise slightly in London on a quiet day for global markets. Market report.

• Source: The Scotsman (Edinburgh, Scotland). 2024, pages. 40

Record details

LETTERS.

• Authors : CANDEE, ANDREA; WRIGHT, CHRISANNA; WORKUM, ANDREW

Subjects: DRUG prices; ECONOMIC aspects of diseases; SEMAGLUTIDE

• Source: New York Times. 4/8/2024, Vol. 173 Issue 60118, pA19-A19. 1/3p.

Record details

Dynatrace Stock Rises On Fiscal Q4 Earnings, $500 Million Buyback.

• Authors : Krause, Reinhardt

• Source: Investor's Business Daily. 2024.

Record details

The AI frenzy comes down to Earth; After ChatGPT's surge in popularity and the stratospheric rise of Nvidia's share price, it appears reality has dawned on the tech sector

• Source: Globe & Mail (Toronto, Canada). May 11, 2024, B5

Record details